The invention relates to a series of pyrrolopyrimidinone derivatives of the formula (1): ##STR1##

    • wherein R1 is H; C1-C3 alkyl optionally substituted with one or more fluoro atoms; or C3-C6 cycloalkyl;
    • R2 is H; a halogen atom; C1-C6 alkyl optionally substituted with OH, C1-C3 alkoxy, C3-C6 cycloalkyl, or with one or more fluoro atoms; C3-C6 cycloalkyl; C2-C6 alkenyl; or C2-C6 alkynyl;
    • R3 is H; C1-C6 alkyl optionally substituted with OH, C1-C3 alkoxy, C3-C6 cycloalkyl, or with one or more fluoro atoms; C3-C6 cycloalkyl; C2-C6 alkenyl; or C2-C6 alkynyl;
    • R4 is C1-C6 alkyl optionally substituted with C3-C6 cycloalkyl or with one or more fluoro atoms; C2-C6 alkenyl; C2-C6 alkynyl; or C3-C6 cycloalkyl; and
    • R5 is SO2NR6R7; NHSO2NR6R7; NHCOCONR6R7; NHSO2R8; NHCOR8; or phenyl or heterocyclyl either of which is optionally substituted with one or more fluoro atoms or C1-C3 alkyl.
  •  
    Web www.patentalert.com

    < Clostridial toxin derivatives able to modify peripheral sensory afferent functions

    < Method for reducing the inflammation and inducing an analgesic effect and compounds thereof

    > Use of DHEA derivatives on keratinous substances

    > Compositions and methods for monitoring the modification of modification dependent binding partner polypeptides

    ~ 00221